• Drug Coverage
  • Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Safety & Recalls
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Lean Medicaid policies cause delays

Article

States and counties with a high prevalence of delayed care had a weaker Medicaid infrastructure

States with restrictive Medicaid eligibility need to alter those policies to reduce delayed medical care, according to a recent New England Journal of Medicine letter to the editor.

Cheryl R. Clark, MD, director of Health Equity Research and Intervention in the Center for Community Health and Health Equity at Brigham and Women’s Hospital and Mark J. Ommerborn, MPH, with Brigham and Women’s Hospital, coauthored new Medicaid research that was published in the NEJM letter, March 28, 2013.

Dr. Clark and colleagues examined county-level geographic variation in the prevalence of delayed care-specifically seeing a physician-because of cost among 280,333 adults in the 2010 Behavioral Risk Factor Surveillance System (BRFSS) survey. The researchers also reviewed the relationship between Medicaid eligibility thresholds for working adults with children and the odds that BRFSS survey participants would delay seeking care.

“Our results suggest stark geographic differences in the prevalence of care delayed because of cost. States and counties with a high prevalence of delayed care had a weaker healthcare infrastructure than states with a lower prevalence of delayed care,” Dr. Clark wrote.

Particularly vulnerable areas were in the South, including Texas and Florida. Populations in counties with the highest prevalence of delayed care were more likely to be Hispanic and have low incomes and a high prevalence of chronic disease. States with more restrictive eligibility will likely need additional investments in Medicaid to catch up to expected coverage levels demanded by the Patient Protection and Affordable Care Act.

Related Videos
Video 9 -"Overcoming Implementation Barriers for Digital Therapeutics Adoption"
Video 6 - "Failing to Reach Ideal Diabetes Care: Equitable Doesn’t Mean Equal"
Video 5 - "Revising Diabetes Outcome Measures"
Video 6 - "Navigating Insurance Coverage for Prescription Digital Therapeutics"
Video 5 - "FDA Approval Pathway for Prescription Digital Therapeutics"
Video 8 - "Gaps in Evidence Generation for Digital Therapeutics"
Video 7 - "Adoption Lessons For Payers"
Video 10 - "Managing Self Care"
Video 3 - "Embracing and Improving Access to Technology Tools"
Related Content
© 2024 MJH Life Sciences

All rights reserved.